Walden E Bjørn-Yoshimoto, Iris Bea L Ramiro, Thomas Lund Koch, Ebbe Engholm, Ho Yan Yeung, Kasper K Sørensen, Carolyn M Goddard, Kathrine L Jensen, Nicholas A Smith, Laurent F Martin, Brian J Smith, Kenneth L Madsen, Knud J Jensen, Amol Patwardhan, Helena Safavi-Hemami
UNLABELLED: Persistent pain affects one in five people worldwide, often with severely debilitating consequences. Current treatment options, which can be effective for mild or acute pain, are ill-suited for moderate-to-severe persistent pain, resulting in an urgent need for new therapeutics. In recent years, the somatostatin receptor 4 (SSTR 4 ), which is expressed in sensory neurons of the peripheral nervous system, has emerged as a promising target for pain relief. However, the presence of several closely related receptors with similar ligand-binding surfaces complicates the design of receptor-specific agonists...
April 30, 2024: bioRxiv